Eledon Pharmaceuticals Ownership | Who Owns Eledon Pharmaceuticals?


OverviewForecastRevenueFinancialsChart

Eledon Pharmaceuticals Ownership Summary


Eledon Pharmaceuticals is owned by 47.27% institutional investors, 1.11% insiders, and 51.62% retail investors. Bvf inc/il is the largest institutional shareholder, holding 8.16% of ELDN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.08% of its assets in Eledon Pharmaceuticals shares.

ELDN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockEledon Pharmaceuticals47.27%1.11%51.62%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bvf inc/il6.29M8.16%$16.30M
Ra capital management3.57M4.62%$9.24M
Blackrock funding, inc. /de3.47M4.49%$8.97M
Vanguard group3.27M4.24%$8.46M
Siren2.07M2.69%$5.37M
Zimmer partners, lp1.82M2.37%$4.73M
Geode capital management1.37M1.77%$3.55M
Wellington management group llp1.28M1.66%$3.33M
Sphera funds management1.28M1.66%$3.32M
Ensign peak advisors1.26M1.64%$3.28M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Cm management600.00K1.30%$1.55B
Velan capital investment management lp346.97K0.84%$898.66K
Sanofi814.98K0.81%$2.11M
Blue owl capital lp979.91K0.79%$2.54M
22nw, lp636.36K0.78%$1.65M
Sphera funds management1.28M0.70%$3.32M
Bvf inc/il6.29M0.66%$16.30M
Catalio capital management, lp1.06M0.51%$2.75M
Exome asset management114.14K0.34%$386.95K
Siren2.07M0.21%$5.37M

Top Buyers

HolderShares% AssetsChange
Siren2.07M0.21%1.38M
Wellington management group llp1.28M0.00%1.28M
Catalio capital management, lp1.06M0.51%1.06M
Zimmer partners, lp1.82M0.10%844.32K
Kovitz investment group partners732.98K0.01%732.98K

Top Sellers

HolderShares% AssetsChange
First light asset management---2.60M
Armistice capital---2.36M
Frazier life sciences management---1.18M
Awm investment company---1.10M
Point72 asset management---1.09M

New Positions

HolderShares% AssetsChangeValue
Catalio capital management, lp1.06M0.51%1.06M$2.75M
Kovitz investment group partners732.98K0.01%732.98K$1.90M
Inspire investing194.69K0.09%194.69K$802.12K
Deutsche bank ag\64.11K0.00%64.11K$166.04K
Brighton jones39.35K0.00%39.35K$101.93K

Sold Out

HolderChange
Ifs advisors-100.00
Raymond james financial-600.00
Jones financial companies lllp-725.00
Ameritas advisory services-1.00K
Citadel advisors-1.40K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2025876.10%36,469,788-9.28%471.74%46-2042.86%
Jun 30, 2025882.33%40,843,2136.23%522.13%4837.14%16-23.81%
Mar 31, 202514-81.82%17,746,490-53.88%290.54%4-93.75%4100.00%
Dec 31, 202417-48.48%4,377,486-76.32%80.67%12---100.00%
Sep 30, 2024336.45%18,485,8271.24%350.96%12-42.86%6500.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.84M3.08%-40.65K
iShares Russell 2000 ETF1.38M2.31%-
Vanguard US Total Market Shares ETF1.15M1.92%-
Vanguard Institutional Extnd Mkt Idx Tr669.79K1.12%-305.20K
Fidelity Small Cap Index582.63K0.97%582.63K
iShares Russell 2000 Value ETF476.67K0.80%-
Fidelity Extended Market Index322.60K0.54%-2.65K
MEDICAL BioHealth EUR Acc294.49K0.49%-
Vanguard Russell 2000 ETF278.86K0.47%-19.43K
State St Russell Sm Cap® Indx SL Cl I206.80K0.35%-

Recent Insider Transactions


DateNameRoleActivityValue
Oct 29, 2024BVF PARTNERS L P/IL-Buy$440.49
Oct 29, 2024BVF PARTNERS L P/IL-Buy$2.10K
Oct 29, 2024BVF PARTNERS L P/IL-Buy$2.21K
May 09, 2024BVF PARTNERS L P/IL-Buy$1.95M
May 09, 2024BVF PARTNERS L P/IL-Buy$232.07

Insider Transactions Trends


DateBuySell
2035 Q1--
2025 Q1--
2024 Q43-
2024 Q26-
2023 Q4--

ELDN Ownership FAQ


Who Owns Eledon Pharmaceuticals?

Eledon Pharmaceuticals shareholders are primarily institutional investors at 47.27%, followed by 1.11% insiders and 51.62% retail investors. The average institutional ownership in Eledon Pharmaceuticals's industry, Biotech Stocks , is 45.22%, which Eledon Pharmaceuticals exceeds.

Who owns the most shares of Eledon Pharmaceuticals?

Eledon Pharmaceuticals’s largest shareholders are Bvf inc/il (6.29M shares, 8.16%), Ra capital management (3.57M shares, 4.62%), and Blackrock funding, inc. /de (3.47M shares, 4.49%). Together, they hold 17.27% of Eledon Pharmaceuticals’s total shares outstanding.

Does Blackrock own Eledon Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Eledon Pharmaceuticals.

Who is Eledon Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Cm management is Eledon Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 1.30% of its assets in 600K Eledon Pharmaceuticals shares, valued at 1.55B$.

Who is the top mutual fund holder of Eledon Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Eledon Pharmaceuticals shares, with 3.08% of its total shares outstanding invested in 1.84M Eledon Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools